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The partial characterization of the structure of the lipoglycan (LG) from Acholeplasma
axanthum is added to the previous complete structural analysis of the lipoglycan from
A. granylarum. The terminal sequence of A. axanthum LG is Glcp(3l -2)-Glcp(31-2)-
Glcp(,lB-6)-; of A. granularum Glcp(,lB-2)-Glcp(al-4)-Glcp(31-4)-. These specific
residues define the major antigenic determinants of the LG as determined by blockage of
hemagglutination of LG coated erythrocytes by specific oligosaccharides and binding of
radiolabeled LG to specific immunoglobulins. The binding of LG to mammalian cells occurs
by an interaction between specific eucaryotic cell receptors and the internal sequence of the
oligosaccharide chain of LG. Size and sugar chains of LG rather than fatty acid residues ap-
pears to define the binding site on the LG.
Acholeplasmal lipoglycans are heteropolysaccharides covalently attached to a
diacyl glycerol [1]. They are membrane-associated and appear to be homogeneous as
to size and structure for each species. However, both size and structure differ be-
tween species. Molecular size differences range from 20,000 to 150,000. These
lipoglycans exhibit antigenic specificty [2,3], are immunogenic [2], adsorb specifi-
cally to mammalian cells [4], induce pyrogenicity in rabbits and clot Limulus lysate
[5], and, in the case ofAcholeplasma laidlawii, serve as a specific receptor for the
enveloped mycoplasmavirus, MVL2 [6].
Lipoglycans from two species, A. granularum andA. axanthum, were selected for
elucidation of the structure of the oligosaccharide chains and subsequent definition
of the role of specific chemical features involved in various biological interactions.
A. granularum was chosen as a representative of a non-pathogen and A. axanthum
as an example of a possible pathogen. The complete structure for the lipoglycan
from A. granularum has been determined [7]. It has a monomeric weight of 20,000
and is composed of glucose, galactose, N-acetylglucosamine, N-acetylfucosamine,
glycerol, and fatty acid esters. It consists of a linear oligosaccharide chain with 12
repeating units of nine sugars:
Glcp(Al -2)-Glcp(al -4)-Glcp(al -3,4)-FcNAc(,B1 -3)-Galp(a1-3)-
Galp(a(1-3)-Galp(a1-3,4)-GlcNAc(01-3,4)-GlcNAc(/3I -4)-
attached to diacylglycerol. Although the position of the linkages (three or four) on
the amino sugars has not been resolved, it is presumed they are on carbon 4 from in-
direct evidence.
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All rights of reproduction in any form reserved.The lipoglycan from A. axanthum has been only partially characterized. Its
monomeric weight is about 100,000 and is composed of glucose, galactose,
N-acylfucosamine, N-acylquinovosamine, glycerol, fatty acids, and phosphorus. A
trace of galactosamine may be present. The existence of phosphorus as an integral
component of the molecule was detected upon attempts to remove traces of con-
taminating nucleic acids by passage through an anion exchange resin. In contrast to
the lipoglycan from A. granularum, the lipoglycan from A. axanthum could not be
eluted with water. Treatment with cold 70 percent HF, which releases inorganic
phosphorus without hydrolysis of glycosidic bonds, liberated half of the galactose
residues of the lipoglycan. Assay of a galactose in the intact molecule with galactose
oxidase, which oxidizes the -CH2OH at the sixth position, likewise detected half of
the galactose. These findings together with the ratio of galactose:P of two indicate
that half of the galactose exists as galactose phosphate side chains. Treatment of the
intact lipoglycan with glycosidases, which should remove appropriate terminal sugar
residues, indicated that the terminal three residues are:-linked glucose, followed by
one,B-linked galactose and then two a-linked glucose residues. Chromium trioxide
oxidation, which selectively destroys fl-linked neutral and amino sugars, resulted in
the loss of six of every eight glucose, one of two galactose, and all of the amino
sugars. Analysis of the products of Smith degradation suggest that all of the galac-
tose residues are linked 1 -6, two of eight glucose residues are linked1-2, three are
1-4, and three are1-3. All of the amino sugars survive periodate oxidation and
are probably linked 1-4. One large fragment remains after Smith degradation
which, after de-N-acylation, appears to contain 12 sugar residues of which three are
glucose, six are fucosamine, and three are quinovasamine. Controlled acid
hydrolysis ofthis fragment yields a trisaccharide of glucose and a pentasaccharide of
fucosamine. All of the phosphorus of the lipoglycan is associated with this 12 sugar
fragment, suggesting that the galactose phosphate residues are distributed evenly
along the molecule on one of the three glucose residues unoxidized by periodate. All
of the amino sugars are N-acylated. Three of every four N-acyl groups are acetyl
while one of four is a long chain fatty acid. Some of these fatty acids are hydroxy
fatty acids. These data and other evidence not mentioned here are suggestive of an
oligosaccharide chain consisting of 24 repeating units of 19 sugar residues each:
Glcp (fl,-2)-Glcp (,I -2)-Glcp (,B1-6)-Galp (,BI -4)-Glcp(aI -4)-
Glcp (ac -4)-FcNAc(,BI-4)-FcNAc(flI-4)-FcNAc(oI -4)-FcNAc(OI -4)-
FcNAc(oI -4)-FcNAc(flI -3)-Glcp(fI -3)-
alp-P-(al -6)
lcp (aI -3)-Glcp (aI-4)-QvNAc(oI -4)-QvNAc(, I -1 4)-QvNAc(OI -2)-
The placement of the fucosamine and quinovosamine segments is arbitrary and
could be reversed. More data are required to confirm this tentative structural ar-
rangement.
Knowledge of the structural features of these two lipoglycans has facilitated an ex-
amination of the specific nature of their antigenic determinants [8]. Specific antisera
were raised against each lipoglycan in rabbits by injection of autologous
erythrocytes coated with appropriate lipoglycan. Two types of experiments were
performed. One type examined the blocking of hemagglutination by specific an-
tiserum of sheep erythrocytes coated with homologous lipoglycan as well as the in-
terference of antibody binding of radiolabeled lipoglycans by unlabeled disac-
charides; the second type examined binding of radiolabeled disaccharide by an-
tibody against lipoglycan.
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Varying concentrations of disaccharides and oligosaccharides (0.5 to 6 mg/ml)
were mixed with a predetermined dilution of antiserum. After incubation for 45
minutes at 37°C, lipoglycan-coated sheep erythrocytes were added. Following 30
minutes at 22°C, microtiter plates were examined for hemagglutination. Among all
of the carbohydrates tested, including all of the possible anomeric and carbon
number linkages of glucose as well as a-galactose-l-phosphate and oligosaccharides
unrelated to lipoglycan structures, hemagglutination of A. granularum lipoglycan
was inhibited completely by sophorose (Glcp(13l-2)-Glcp, 2 mg/ml) and maltose
(Glcp(al-4)-Glcp, 4 mg/ml), while for A. axanthum, only sophorose (2 mg/ml)
was effective. These results are compatible with the terminal sugar sequences ofboth
lipoglycans and indicates that the terminal three sugar units of each oligosaccharide
chain define the antigenic specificity. The first two sugar radicals exert a greater in-
fluence than the second and third since maltose was less effective in the case of A.
granularum lipoglycan than sophorose. Furthermore, the identical nature of the ter-
minal two sugar radicals in both lipoglycans explains the cross-reactivity oftheir an-
tisera. Pretreatment of antisera against both lipoglycans with unlabeled sophorose
was followed by addition of an excess amount of lipoglycans, labeled with
14C-palmitic acid. Immunoglobulins were then precipitated with cold ammonium
sulfate [9], washed, and counted. In both cases increasing amounts of sophorose
caused decreasing adsorption of radiolabeled lipoglycans to immune globulins
(Table 1). No such effect was noted with normal serum.
The availability of 14C-maltose permitted examination of its binding to immune
globulins against both lipoglycans (Table 2). The amount ofmaltose bound was pro-
portional to the dilution of antiserum againstA. granularum lipoglycan. No signifi-
cant binding occurred with either normal serum or antiserum against A. axanthum
lipoglycan, as would be predicted from the oligosaccharide structures.
It has been reported previously that acholeplasmal lipoglycans bind to sheep and
rabbit erythrocytes and to cultured mouse fibroblasts and rabbit epidermal cells [4].
The receptor sites on these eucaryotic cells are distinct for the lipoglycans since
gram-negative bacterial lipopolysaccharides do not compete for binding of
lipoglycans. The lipoglycan receptor has been isolated and characterized as a
lipoglycoprotein from a variety ofeucaryotic cell types [10]. However, this aspect of
the study is not the subject of this report. Rather, attempts to define the portion of
the lipoglycan molecule which is involved in attachment to erythrocytes will be
TABLE I
Inhibition of Binding of Radiolabeled Lipoglycans by Unlabeled Sophorose
A. granularum A. axanthum
Lipoglycan Binding Lipoglycan Binding
(Counts per Minute) (Counts per Minute)
Sophorose Sophorose
Added Specific Normal Added Specific Normal
(mg) Antiserum Serum (mg) Antiserum Serum
0 41,621 801 0 3,886 -
0.5 37,831 689 0.4 2,841 -
1.0 32,531 628 0.8 2,503 -
1.25 2,392 490
2.0 27,120 823 5.0 1,296 137
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TABLE 2
Binding of '4C-maltose to Immune Globulins in Antiserum
Against Lipoglycan from A. granularum
Maltose Bound
(Counts per minute)
Specific Antiserum
Serum Dilution A. granularum Normal Serum
1:2 19,150 1,120
1:4 6,823 580
1:8 4,362 253
1:16 1,250 123
1:32 126 68
presented. Obviously, the terminal sugar sequences of the oligosaccharide chains are
not involved since lipoglycans bound to erythrocytes react with specific antisera.
Lipoglycans fromA. granularum andA. axanthum were preincubated with a variety
of compounds, including mono-, di-, and oligosaccharides, proteins (bovine serum
albumin, hemoglobin, glycophorin), and amino acids to determine their effect on at-
tachment or competition for binding sites on erythrocytes. In no case was any inhibi-
tion observed that could not be considered non-specific, i.e., >200 gg/ml.
Periodate-oxidized, borohydride-reduced lipoglycans were capable of binding to
erythrocyte receptors although these coated erythrocytes no longer could agglutinate
in the presence of specific antisera against lipoglycans. Exposure of erythrocytes,
pretreated with oxidized lipoglycans, to untreated lipoglycans also were no longer
capable of hemagglutination. Apparently the receptor sites on the erythrocytes were
occupied with lipoglycans on which the antigenic determinants had been destroyed.
Deacylation of the lipoglycan from A. granularum destroyed its capacity to bind
to erythrocytes. However, deacylation of the lipoglycan from A. axanthum had no
effect. Since A. axanthum lipoglycan contains N-acyl fatty acid residues, these
would not be removed by mild alkali. Hence, a deacylated lipoglycan from another
species, A. modicum, was examined. This deacylated lipoglycan exists as a
monomer, a dimer, and a tetramer [3]. The dimer and tetramer retained the ability
to attach to erythrocytes. Therefore, it would appear that size rather than fatty acid
residues is important for binding. The monomer weight of the lipoglycan from A.
granularum is 20,000, from A. modicum 36,000, and from A. axanthum 100,000.
The smallest molecule found to bind to erythrocytes was the dimer from A.
modicum, which possesses a size of 72,000 daltons. Intact lipoglycans exist in
polymeric form and this fact probably explains why all bind to mammalian cells.
Presumably, internal segments of oligosaccharide chain are involved. Further
evidence of the non-involvement of fatty acyl groups was the finding that
simultaneous or pre-exposure of erythrocyte receptors to glycolipids, acylated
glucose, and acylated polysaccharides had no effect on lipoglycan binding.
The biological significance of these lipoglycans from Acholeplasma, which are
considered non-pathogenic, is not clear. Likely possibilities include the expression of
a distinctive surface property for each species, stabilization of the cell membrane,
and, in the case of biological interactions, modulation of the immune response.ACHOLEPLASMAL LIPOGLYCANS 429
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